Singapore Deep Brain Stimulation Devices Market Size & Outlook
Singapore deep brain stimulation devices market, 2018-2030 (US$M)
Related Markets
Singapore deep brain stimulation devices market highlights
- The Singapore deep brain stimulation devices market generated a revenue of USD 9.1 million in 2024 and is expected to reach USD 17.2 million by 2030.
- The Singapore market is expected to grow at a CAGR of 11.5% from 2025 to 2030.
- In terms of segment, dystonia was the largest revenue generating application in 2024.
- Epilepsy is the most lucrative application segment registering the fastest growth during the forecast period.
Deep brain stimulation devices market data book summary
| Market revenue in 2024 | USD 9.1 million |
| Market revenue in 2030 | USD 17.2 million |
| Growth rate | 11.5% (CAGR from 2025 to 2030) |
| Largest segment | Dystonia |
| Fastest growing segment | Epilepsy |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pain Management, Epilepsy, Essential Tremor, Obsessive Compulsive Disorder (OCD), Parkinsons Disease, Depression, Dystonia |
| Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Other key industry trends
- In terms of revenue, Singapore accounted for 0.6% of the global deep brain stimulation devices market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan deep brain stimulation devices market is projected to lead the regional market in terms of revenue in 2030.
- Thailand is the fastest growing regional market in Asia Pacific and is projected to reach USD 17.8 million by 2030.
Dystonia was the largest segment with a revenue share of 71.43% in 2024. Horizon Databook has segmented the Singapore deep brain stimulation devices market based on pain management, epilepsy, essential tremor, obsessive compulsive disorder (ocd), parkinsons disease, depression, dystonia covering the revenue growth of each sub-segment from 2018 to 2030.
Moreover, this country has an open trade policy, thus it has no barriers to trade and custom duties on medical devices. Thus, adoption of neurostimulators for deep brain stimulation is expected to grow in the coming years.
Furthermore, Singapore offers universal coverage and large government subsidies are available to assist patients with critical care needs although private & government administered medical insurance is available.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Deep Brain Stimulation Devices Market Scope
Deep Brain Stimulation Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Singapore deep brain stimulation devices market size, by application, 2018-2030 (US$M)
Singapore Deep Brain Stimulation Devices Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
